Developmental stage dependent neural stem cells sensitivity to methylmercury chloride on different biofunctional surfaces

Toxicology in Vitro

Volumn 28, Issue 1, 2014, Pages 76-87

  Zychowicz, M ^a   Dziedzicka, D ^b   Mehn, D ^c   Kozlowska, H ^a   Kinsner Ovaskainen, A ^c   Stepien P P ^b   Rossi, F ^c   Buzanska, L ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c JOINT RESEARCH CENTRE   (Italy)

Author keywords

Bioactive domains; Developmental neurotoxicity; MeHgCl sensitivity; Neural stem cells

Indexed keywords

BETA TUBULIN; BETA TUBULIN 3; FIBRONECTIN; METHYLMERCURIC CHLORIDE; POLYLYSINE; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; BIOFUNCTIONAL SURFACE; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPMENTAL SENSITIVITY; DEVELOPMENTAL STAGE; HUMAN; HUMAN CELL; NEURAL STEM CELL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; STATIC ELECTRICITY; SURFACE PROPERTY;

BIOACTIVE DOMAINS; DEVELOPMENTAL NEUROTOXICITY; MEHGCL SENSITIVITY; NEURAL STEM CELLS;

CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; HUMANS; METHYLMERCURY COMPOUNDS; NEURAL STEM CELLS; NEUROTOXICITY SYNDROMES; POLYLYSINE; TIME FACTORS; VITRONECTIN;

EID: 84888302268     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.06.023     Document Type: Article

References (51)

1. Bal-Price A.K., Coecke S., Costa L., Crofton K.M., Fritsche E., Goldberg A., Grandjean P., Lein P.J., Li A., Lucchini R., Mundy W.R., Padilla S., Persico A.M., Seiler A.E., Kreysa J. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX 2012, 29:202-215.
2. Berthiaume F., Moghe P.V., Toner M., Yarmush M.L. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J. 1996, 10:1471-1484.
3. Burke K., Cheng Y., Li B., Petrov A., Joshi P., Berman R.F., Reuhl K.R., DiCicco-Bloom E. Methylmercury elicits rapid inhibition of cell proliferation in the developing brain and decreases cell cycle regulator, cyclin E. Neurotoxicology 2006, 27:970-981.
4. Buzanska L., Sypecka J., Nerini-Molteni S., Compagnoni A., Hogberg H.T., del Torchio R., Domanska-Janik K., Zimmer J. A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells 2009, 27:2591-2601.
5. Buzanska L., Ruiz A., Zychowicz M., Rauscher H., Ceriotti L., Rossi F., Colpo P., Domanska-Janik K., Coecke S. Patterned growth and differentiation of human cord blood-derived neural stem cells on bio-functionalized surfaces. Acta Neurobiol. Exp. (Wars) 2009, 69:24-36.
6. Buzanska L., Zychowicz M., Ruiz A., Ceriotti L., Coecke S., Rauscher H., Sobanski T., Whelan M., Domanska-Janik K., Colpo P., Rossi F. Neural stem cells from human cord blood on bioengineered surfaces-novel approach to multiparameter bio-tests. Toxicology 2010, 270:35-42.
7. Castoldi A.F., Coccini T., Ceccatelli S., Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res. Bull. 2001, 55:197-203.
8. Ceriotti L., Buzanska L., Rauscher H., Mannelli I., Zychowicz M., Gilliland D., Hasiwa M., Bretagnol F., Ruiz A., Bremer S., Coecke S., Colpo P., Rossi F. Fabrication and characterization of protein arrays for stem cells patterning. Soft Matters 2009, 5:1406-1416.
9. Clarkson T.W. The toxicology of mercury. Crit. Rev. Clin. Lab. Sci. 1997, 34:369-403.
10. Coecke S., Goldberg A.M., Allen S., Buzanska L., Calamandrei G., Crofton K., Hareng L., Hartung T., Knaut H., Honegger P., Jacobs M., Lein P., Li A., Mundy W., Owen D., Schneider S., Silbergeld E., Reum T., Trnovec T., Monnet-Tschudi F., Bal-Price A. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ. Health Perspect. 2007, 115:924-931.
11. Colleoni S., Galli C., Gaspar J.A., Meganathan K., Jagtap S., Hescheler J., Sachinidis A., Lazzari G. Characterisation of a neural teratogenicity assay based on human ESCs differentiation following exposure to valproic acid. Curr. Med. Chem. 2012, (Epub ahead of print).
12. Crofton K.M., Mundy W.R., Lein P.J., Bal-Price A., Coecke S., Seiler A.E., Knaut H., Buzanska L., Goldberg A. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX 2010, 28:9-15.
13. Crofton K.M., Mundy W.R., Shafer T.J. Developmental neurotoxicity testing: a path forward. Congenit. Anom. (Kyoto) 2012, 52:140-146.
14. Culbreth M.E., Harrill J.A., Freudenrich T.M., Mundy W.R., Shafer T.J. Comparison of chemical-induced changes in proliferation and apoptosis in human and mouse neuroprogenitor cells. Neurotoxicology 2012, (PMID: 22634143).
15. Falconnet D., Csucs G., Grandin H.M., Textor M. Surface engineering approaches to micropattern surfaces for cell-based assays. Biomaterials 2006, 27:3044-3063.
16. Farina M., Rocha J.B., Aschner M. Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci. 2011, 89:555-563.
17. Fernandes T.G., Diogo M.M., Clark D.S., Dordick J.S., Cabral J.M. High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol. 2009, 27:342-349.
18. Fritsche E., Gassmann K., Schreiber T. Neurospheres as a model for developmental neurotoxicity testing. Methods Mol. Biol. 2011, 758:99-114.
19. Garrido S.M., Appelbaum F.R., Willman C.L., Banker D.E. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp. Hematol. 2001, 29:448-457.
20. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
21. Guengerich F.P. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 2006, 8:E101-E111.
22. Hogberg H.T., Bal-Price A.K. Domoic acid-induced neurotoxicity is mainly mediated by the AMPA/KA receptor: comparison between immature and mature primary cultures of neurons and glial cells from rat cerebellum. J. Toxicol. 2011, 2011:1-14.
23. Hunter D., Russell D.S. Focal cerebellar and cerebellar atrophy in a human subject due to organic mercury compounds. J. Neurol. Neurosurg. Psychiatry 1954, 17:235-241.
24. Kirsch-Volders M., Decordier I., Elhajouji A., Plas G., Aardema M.J., Fenech M. In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis 2011, 26:177-184.
25. Kuegler P.B., Zimmer B., Waldmann T., Baudis B., Ilmjärv S., Hescheler J., Gaughwin P., Brundin P., Mundy W., Bal-Price A.K., Schrattenholz A., Krause K.H., van Thriel C., Rao M.S., Kadereit S., Leist M. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 2010, 27:17-42.
26. Lee M.R., Kwon K.W., Jung H., Kim H.N., Suh K.Y., Kim K., Kim K.S. Direct differentiation of human embryonic stem cells into selective neurons on nanoscale ridge/groove pattern arrays. Biomaterials 2010, 31:4360-4366.
27. Mackay-Sim A. Patient-derived stem cells: pathways to drug discovery for brain diseases. Front. Cell. Neurosci. 2013, 7:1-10.
28. Meganathan K., Jagtap S., Wagh V., Winkler J., Gaspar J.A., Hildebrand D., Trusch M., Lehmann K., Hescheler J., Schlüter H., Sachinidis A. Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS ONE 2012, 8:e44228.
29. Moors M., Rockel T.D., Abel J., Cline J.E., Gassmann K., Schreiber T., Schuwald J., Weinmann N., Fritsche E. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 2009, 117:1131-1138.
30. Nefedova Y., Landowski T.H., Dalton W.S. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 2003, 17:1175-1182.
31. Newland M.C., Paletz E.M., Reed M.N. Methylmercury and nutrition: adult effects of fetal exposure in experimental models. Neurotoxicology 2008, 29:783-801.
32. Nerini-Molteni S., Mennecozzi M., Fabbri M., Sacco M.G., Vojnits K., Compagnoni A., Gribaldo L., Bremer-Hoffmann S. MicroRNA profiling as a tool for pathway analysis in a human in vitro model for neural development. Curr. Med. Chem. 2012, (Epub ahead of print).
33. Orrenius S., Nicotera P., Zhivotovsky B. Cell death mechanisms and their implications in toxicology. Toxicol. Sci. 2011, 119:3-19.
34. Reilly G.C., Engler A.J. Intrinsic extracellular matrix properties regulate stem cell differentiation. J. Biomech. 2010, 43:55-62.
35. Riquelme P.A., Drapeau E., Doetsch F. Brain micro-ecologies: neural stem cell niches in the adult mammalian brain. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2008, 363:123-137.
36. Ruiz A., Buzanska L., Gilliland D., Rauscher H., Sirghi L., Sobanski T., Zychowicz M., Ceriotti L., Bretagnol F., Coecke S., Colpo P., Rossi F. Micro-stamped surfaces for the patterned growth of neural stem cells. Biomaterials 2008, 29:4766-4774.
37. Ruiz S.A., Chen C.S. Emergence of patterned stem cell differentiation within multicellular structures. Stem Cells 2008, 26:2921-2927.
38. Rodier P.M. Developing brain as a target of toxicity. Environ. Health Perspect. 1995, 6:73-76.
39. Sager P.R., Doherty R.A., Olmsted J.B. Interaction of methylmercury with microtubules in cultured cells and in vitro. Exp. Cell Res. 1983, 146:127-137.
40. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
41. Skalamera D., Ranall M.V., Wilson B.M., Leo P., Purdon A.S., Hyde C., Nourbakhsh E., Grimmond S.M., Barry S.C., Gabrielli B., Gonda T.J. A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PLoS ONE 2011, 6:e20057.
42. Speit G., Vasquez M., Hartmann A. The comet assay as an indicator test for germ cell genotoxicity. Mutat. Res. 2009, 681:3-12.
43. Tamm C., Duckworth J., Hermanson O., Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J. Neurochem. 2006, 97:69-78.
44. Tandon N., Marolt D., Cimetta E., Vunjak-Novakovic G. Biotechnol Adv. 2013, (Epub ahead of print). 10.1016/j.biotechadv.2013.03.007.
45. Tegenge M.A., Rockel T.D., Fritsche E., Bicker G. Nitric oxide stimulates human neural progenitor cell migration via cGMP-mediated signal transduction. Cell Mol. Life Sci. 2011, 68:2089-2099.
46. Walker J.L., Fournier A.K., Assoian R.K. Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension. Cytokine Growth Factor Rev. 2005, 16:395-405.
47. Wu M.H., Huang S.B., Lee G.B. Microfluidic cell culture systems for drug research. Lab Chip. 2010, 10:939-956.
48. Visan A., Hayess K., Sittner D., Pohl E.E., Riebeling C., Slawik B., Gulich K., Oelgeschläger M., Luch A., Seiler A.E. Neural differentiation of mouse embryonic stem cells as a tool to assess developmental neurotoxicity in vitro. Neurotoxicology 2012, 33:1135-1146.
49. Zimmer B., Lee G., Balmer N.V., Meganathan K., Sachinidis A., Studer L., Leist M. Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells. Environ. Health Perspect. 2012, 120:1116-1122.
50. Zychowicz M., Mehn D., Ruiz A., Colpo P., Rossi F., Frontczak-Baniewicz M., Domanska-Janik K., Buzanska L. Proliferation capacity of cord blood derived neural stem cell line on different micro-scale biofunctional domains. Acta Neurobiol. Exp. (Wars) 2011, 71:12-23.
51. Zychowicz M., Mehn D., Ruiz A., Frontczak-Baniewicz M., Rossi F., Buzanska L. Patterning of human cord blood-derived stem cells on single cell posts: implications for neural commitment. Acta Neurobiol. Exp. (Wars) 2012, 72:325-336.